FULVESTRANT is a Intramuscular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Northstar Rx, Llc,. The primary component is Fulvestrant.
| Product ID | 16714-070_244e8f58-8aba-5ede-0b9d-a566f1021cfb |
| NDC | 16714-070 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FULVESTRANT |
| Generic Name | Fulvestrant |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2021-08-23 |
| Marketing Category | ANDA / |
| Application Number | ANDA213553 |
| Labeler Name | Northstar Rx, LLC, |
| Substance Name | FULVESTRANT |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2021-08-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9022 | Fulvestrant | Fulvestrant |
| 0310-7720 | Fulvestrant | Fulvestrant |
| 0591-5019 | Fulvestrant | Fulvestrant |
| 0781-3079 | Fulvestrant | Fulvestrant |
| 0781-3492 | Fulvestrant | Fulvestrant |
| 16714-070 | FULVESTRANT | fulvestrant |
| 16714-118 | Fulvestrant | Fulvestrant |
| 16729-436 | FULVESTRANT | Fulvestrant |
| 25021-462 | fulvestrant | fulvestrant |
| 43598-262 | Fulvestrant | Fulvestrant |
| 70121-1463 | Fulvestrant | Fulvestrant |
| 63323-715 | Fulvestrant | Fulvestrant |
| 67457-311 | Fulvestrant | Fulvestrant |
| 68462-317 | Fulvestrant | Fulvestrant |
| 70534-002 | fulvestrant | fulvestrant |
| 68001-424 | fulvestrant | fulvestrant |
| 68842-301 | Fulvestrant | Fulvestrant |
| 70860-211 | Fulvestrant | Fulvestrant |
| 71288-555 | Fulvestrant | Fulvestrant |
| 71731-6121 | Fulvestrant | Fulvestrant |
| 72603-105 | Fulvestrant | Fulvestrant |
| 0310-0720 | FASLODEX | Fulvestrant |